eli lilly tirzepatide news today Remember when I told you the FDA warning letters were just the beginning? Yeah….well let’s go…, Yesterday published an open letter on their investor page warning about compounded FDA Approves Lilly's Zepbound™ (tirzepatide)

Master Antioxidant for Cellular Detoxification Support*

2c,d and Extended Data Fig

Evidence suggests that remission is more likely in individuals with early type 2 diabetes (T2D) who are not using insulin therapy and who can engage in significant weight loss

Retatrutide, by contrast, remains investigational, with data extending to around 4868 weeks so far

gesehen bei viralen Infektionen, AIDS, Malignomen, Xenobiotika/-Schwermetallbelastung, Arteriosklerose (Lipidperoxide, erkennbar am erhhten MDA-LDL!), einigen Autoimmunerkrankungen (SLE, rheumatoide Arthritis) sowie neuro-degenerativen Erkrankungen

You can either give us a call on 01708 225555 or send an email to [email protected] and well get back to you as soon as possible